11,373 Shares in The Clorox Company $CLX Bought by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. bought a new stake in The Clorox Company (NYSE:CLXFree Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,373 shares of the company’s stock, valued at approximately $1,085,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Caitlin John LLC boosted its stake in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares during the last quarter. Avalon Trust Co bought a new position in shares of Clorox in the 2nd quarter valued at about $29,000. Darwin Wealth Management LLC acquired a new stake in shares of Clorox in the second quarter valued at about $29,000. Root Financial Partners LLC increased its position in shares of Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares during the last quarter. Finally, SHP Wealth Management bought a new stake in Clorox during the fourth quarter worth about $35,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Down 2.0%

Clorox stock opened at $105.08 on Wednesday. The stock has a 50-day simple moving average of $99.35 and a 200 day simple moving average of $102.92. The stock has a market capitalization of $12.71 billion, a P/E ratio of 21.80, a PEG ratio of 3.35 and a beta of 0.54. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $128.90.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same quarter in the prior year, the company earned $2.87 earnings per share. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Analysts expect that The Clorox Company will post 5.8 earnings per share for the current year.

Clorox Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be paid a $1.25 dividend. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date is Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a yield of 4.8%. Clorox’s dividend payout ratio (DPR) is currently 103.73%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CLX. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Citigroup upped their price objective on Clorox from $97.00 to $100.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Wells Fargo & Company increased their price objective on Clorox from $95.00 to $102.00 and gave the company an “equal weight” rating in a report on Tuesday, August 4th. UBS Group increased their price objective on Clorox from $100.00 to $105.00 and gave the company a “neutral” rating in a report on Tuesday, August 4th. Finally, Barclays reissued an “underweight” rating and issued a $84.00 target price on shares of Clorox in a research note on Tuesday, August 4th. Twelve equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to MarketBeat, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $102.40.

Check Out Our Latest Research Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.